A phase 2 study of ofatumumab in Waldenström’s macroglobulinaemia

Por Furman¹, Richard R, Eradat, Herbert A, DiRienzo, Christine G, Hofmeister, Craig C, Hayman, Suzanne R, Leonard, John P, Coleman, Morton, Advani, Ranjana, Chanan-Khan, Asher, Switzky, Julie, Liao, Qiming M, Shah, Damini, Jewell, Roxanne C, Lisby, Steen, Lin, Thomas S
Publicado no Lancet Haematol (2016)